Therapeutic Asset Ratings
315 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Elranatamab
Acute Myeloid Leukemia
CellCentric Ltd.
P1/2
CC
(40)
Eras-007
Acute Myeloid Leukemia
Erasca, Inc.
P1/2
CC
(40)
Eras-601
Acute Myeloid Leukemia
Erasca, Inc.
P1/2
CC
(40)
Expanded Haploidentical Nk Cells
Acute Myeloid Leukemia
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
P1/2
CC
(40)
Ex-Vivo Expanded Γδ T Cell Infusion
Acute Myeloid Leukemia
Chinese PLA General Hospital
P1/2
CC
(40)
imm01
Acute Myeloid Leukemia
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
P1/2
CC
(40)
immunoglobulin G4-kappa, anti-[Homo sapiens CD47 (CD47 molecule, integrin associated protein, IAP, MER6, OA3)] and anti-[Homo sapiens CD274 (programmed cell death 1 ligand 1, PDL1, PD-L1, B7 homolog 1, B7H1, B7-H1, PDCD1LG1)], humanized monoclonal antibody, bispecific, bivalent
Acute Myeloid Leukemia
Mabwell (Shanghai) Bioscience Co., Ltd.
P1/2
CC
(40)
Inobrodib
Acute Myeloid Leukemia
CellCentric Ltd.
P1/2
CC
(40)
Lanraplenib
Acute Myeloid Leukemia
Kronos Bio
P1/2
CC
(40)
Mezigdomide
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CC
(40)
Mobinitinib
Acute Myeloid Leukemia
Ellipses Pharma
P1/2
CC
(40)
muc1/cll1/cd33/cd38/cd56/cd123-specific gene-engineered t cells
Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(40)
Muc-1 Peptide Vaccine
Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(40)
Ntla-5001
Acute Myeloid Leukemia
Intellia Therapeutics
P1/2
CC
(40)
Petiveria Alliacea Preparation
Acute Myeloid Leukemia
Hospital Universitario San Ignacio
P1/2
CC
(40)
rp7214
Acute Myeloid Leukemia
Rhizen Pharmaceuticals SA
P1/2
CC
(40)
sar443579
Acute Myeloid Leukemia
Sanofi
P1/2
CC
(40)
Sulfasalazine
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris
P1/2
CC
(40)
Syhx1903
Acute Myeloid Leukemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
P1/2
CC
(40)
Teclistamab
Acute Myeloid Leukemia
CellCentric Ltd.
P1/2
CC
(40)
Tgrx-814
Acute Myeloid Leukemia
Shenzhen TargetRx Co., Ltd.
P1/2
CC
(40)
Tozinameran
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris
P1/2
CC
(40)
tqb3454
Acute Myeloid Leukemia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P1/2
CC
(40)
Universal Donor Natural Killer Cells
Acute Myeloid Leukemia
Nationwide Children's Hospital
P1/2
CC
(40)
White Blood Cells/Granulocytes
Acute Myeloid Leukemia
University of Manchester
P1/2
CC
(40)
Showing 176 to 200 of 315 assets
Previous
Page 8 of 13
Next
